What are drug utilization studies?
Drug utilization studies (DUS) were defined by the World Health Organization as studying the marketing, distribution, prescription, and use of medicinal products in a society, with special emphasis on the resulting medical and socioeconomic consequences (WHO, 2003).
What is drug utilization process?
Drug utilization review (DUR) is defined as an authorized, structured, ongoing review of prescribing, dispensing and use of medication. DUR encompasses a drug review against predetermined criteria that results in changes to drug therapy when these criteria are not met.
What is the importance of drug utilization studies in health research?
DUR studies and use of ATC/DDD system will be useful for assessing and comparing medicines use across countries and can contribute to public health policy decisions and resource allocations.
What is due and Dur?
(at individual patient level). Drug or disease specific and it will assess the actual process of prescribing, dispensing, or administration of a drug( indications, dose, drug interactions etc..) DUE is almost same as DRUG UTILIZATION REVIEW (DUR) and these terms are used synonymously.
Who introduced drug utilization research?
Drug utilization research was defined by WHO in 1977 as «the marketing, distribution, prescription, and use of drugs in a society, with special emphasis on the resulting medical, social and economic consequences».
What are the types of utilization review?
Utilization review contains three types of assessments: prospective, concurrent, and retrospective.
What is drug utilization management?
Utilization management is a collection of treatment review and cost reduction techniques used by health insurers and health plans. Health plans frequently employ utilization management techniques in their prescription drug benefit, particularly for high-cost specialty medications.
What are prescribing indicators?
The purpose of the indicators is to identify hospital admissions that may be associated with prescribing that potentially increases the risk of harm, and to quantify patients at potentially increased risk. The indicators aim to: support local reviews of prescribing, alongside other risk factors for potential harm.
What is the conclusion of drug abuse?
Drug use and addiction cause a lot of disease and disability in the world. Recent advances in neuroscience may help improve policies to reduce the harm that the use of tobacco, alcohol, and other psychoactive drugs impose on society.
What is MedDRA in pharmacovigilance?
Abstract. MedDRA (Medical Dictionary tor Regulatory Activities) is a standardised medical terminology, published by the International Council for Harmonisation, used in particular for coding cases of adverse effects in clinical study reports and pharmacovigilance databases, and to facilitate searches in these databases …
What is IND and NDA?
The Investigational New Drug (IND) application falls into the first category, while the New Drug Application (NDA), Abbreviated New Drug Application (ANDA), and Biologics License Application (BLA) fall into the second category.
What are the sources of data on drug utilization?
Sources of data on drug utilization 1. Large data base 2. Data from drug regulatory agencies 3. Supplier/distribution data 4. Practice setting data a) Prescribing data b) Dispensing data c) Aggregate data d) OTC & Pharmacist-prescribed drugs e) Telephone & Internet prescribing 5.
What is a drug utilization review?
• Drug Utilization Reviews (DUR), also referred to as Drug Utilization Evaluations (DUE) or Medication Utilization Evaluations (MUE), are defined as an authorized, structured, ongoing review of healthcare provider prescribing, pharmacist dispensing, and patient use of medication.
What is drug utilization and indication focused testing?
Drug focused: Drug utilization evaluation of a single drug (e.g. Ceftriaxone) or a class of drugs (e.g. Cephalosporin) is tested. 2. Indication focused: Evaluation of drug or drugs that is used for specific indication is examined for their use. 3.
What are the common targets for qualitative drug-drug interaction studies?
Qualitative DUE studies 7. Common targets for DUE includes: Commonly prescribed drugs Drugs associated with potentially significant drug interactions Expensive drugs New drugs Drugs with narrow therapeutic index Drugs that frequently cause serious ADR Drugs used in high risk patient